Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0H1UY
|
||||
| Former ID |
DIB003066
|
||||
| Drug Name |
RQ-00000010
|
||||
| Synonyms |
CJ-033466; PF-01354082; RQ-10; 5-HT 4 receptor partial agonist (GERD), RaQualia; 5-HT4 receptor partial agonist (gastric motility disorder), Pfizer; 5-hydroxytryptamine 4 receptor partial agonist (gastric motility disorder), Pfizer; 5-hydroxytryptamine 4 receptor partial agonist (gastroesophageal reflux), RaQualia
|
||||
| Indication | Gastric motility disorder [ICD10:K22.4] | Investigative | [543971] | ||
| Company |
Pfizer Inc
|
||||
| Canonical SMILES |
c12c(cc(c(n1cc(n2)C)N)Cl)C(=O)NCC1CCN(CC1)CC(C)C
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 4 receptor | Target Info | Agonist | [543971] | |
| PathWhiz Pathway | Excitatory Neural Signalling Through 5-HTR 4 and Serotonin | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.